Diana Hausman - May 9, 2024 Form 4 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Role
Chief Medical Officer
Signature
/s/ Andrea Paul, attorney-in-fact for Diana Hausman
Stock symbol
ZNTL
Transactions as of
May 9, 2024
Transactions value $
-$42,353
Form type
4
Date filed
5/9/2024, 07:46 PM
Previous filing
Feb 5, 2024
Next filing
Jun 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZNTL Common Stock Sale -$42.4K -3.36K -0.89% $12.62 374K May 9, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person.

Remarks:

Exhibit 24 - Power of Attorney